UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031293
Receipt number R000033465
Scientific Title Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the effect of Oligonol on the reduction of body weight and body fat for healthy subjects.
Date of disclosure of the study information 2018/05/01
Last modified on 2018/02/14 09:00:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the effect of Oligonol on the reduction of body weight and body fat for healthy subjects.

Acronym

Clinical study for the evaluation of ameliorative effects of Oligonol on body weight and body fat.

Scientific Title

Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the effect of Oligonol on the reduction of body weight and body fat for healthy subjects.

Scientific Title:Acronym

Clinical study for the evaluation of ameliorative effects of Oligonol on body weight and body fat.

Region

Japan


Condition

Condition

Healyhy subjects whose BMI is 23-30

Classification by specialty

Nursing Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of Oligonol ingestion on body weight and body fat.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Body weight, Body fat mass, Body fat percentage, BMI

Key secondary outcomes

BDHQ, nutrient intake


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The subjects take the Oligonol during two months

Interventions/Control_2

The subjects take the placebo during two months.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Aged 20-60
(2) MBI 23-30
(3) Person who is able to come the test place at the days of measurement
(4) Person who has no diseases relating obesity
(5) Person who was diagnosed as health by doctor
(6) Person who can hold back excessive eating and drinking

Key exclusion criteria

(1) Person ingesting the drugs, supplements and health food products relating lipid metabolism
(2) Patients with chronic disease and medicated
(3) Heavy smoker (>21 pieces/day)
(4) Heavy drunker(>20 g/day of alcohol)
(5) Person who has the allergy with food and drug, especially, lychee, tea, gelatin, pork)
(6) Pregnancy, willing the be pregnant, or breast-feeding.
(7) Person who cannot stop taking excess polyphenolic ingredient such as tea and green tea
(8) Person who is judged as unfit for the subject by the principal investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takayuki Ikeda

Organization

Fuji Women's University

Division name

Faculty of Human Life Sciences

Zip code


Address

Hanakawa Minami 4jo-5, Ishikari-shi, Hokkaido, Japan

TEL

0133-74-7389

Email

ikeda@fujijoshi.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takayuki Ikeda

Organization

Fuji Women's University

Division name

Faculty of Human Life Sciences

Zip code


Address

Hanakawa Minami 4jo-5, Ishikari-shi, Hokkaido, Japan

TEL

0133-74-7389

Homepage URL


Email

ikeda@fujijoshi.ac.jp


Sponsor or person

Institute

Fuji Women's University

Institute

Department

Personal name



Funding Source

Organization

Amino Up Chemical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 10 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 14 Day

Last modified on

2018 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033465


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name